Vol 6, No 3 (2025). Jul-Sep

Published: 2025-09-30

Review articles

Targeted mechanisms and novel therapeutic strategies against extended-spectrum beta-lactamases: From precise detection to intelligent management of bacterial resistance

Abolfazl Jafari-Sales, Aylin Golestani, Zahra Ghahremani, Mohammadmahdi Salek-Faramarzi, Mehrdad Pashazadeh, Aram Asareh Zadegan Dezfuli

51-57
- Full-text PDF
- Persian Abstract
DOI: https://doi.org/10.61882/jcbior.6.3.312
Post-COVID-19 invasive fungal infections in pulmonary ICU patients: Diagnosis, management, and clinical challenge

Niloofar Keikhaei, Hossein Azarmina, Kamyar Kharazmi, Mohsen Farrokhpour

58-67
- Full-text PDF
- Persian Abstract
DOI: https://doi.org/10.61882/jcbior.6.3.330

Original articles

Prevalence of hospital-acquired infections in burn patients: A six-year experience from northern Iran

Pejman Hassanpoor, Mahsa Salimi, Mohammadreza Mobayen, Ezat Hesni

68-71
- Full-text PDF
- Persian Abstract
DOI: https://doi.org/10.61882/jcbior.6.3.320
The CRISPR‒Cas9 system for genome editing of the ASS1 gene in human cells to predict its effect on HSV-1 replication

Nastaran Khodadad, Mona Fani, Mahboobeh Khodadad, Shokufeh Akbarinia, Zahra Goodarzi, Ali Teimoori

72-79
- Full-text PDF
- Persian Abstract
DOI: https://doi.org/10.61882/jcbior.6.3.326
Effect of anticoagulant therapy on the severity symptoms of hospitalized patients with COVID-19

Iraj Jafaripour, Naghmeh Zieaie Amiri, Masoumeh Bayani, Mohammad Taghi Hedayati Goudarzi, Saeed Abrotan, Mehrdad Saravi, Kamyar Amin, Farzad Jalali, Hoda Shirafkan, Roghayeh Pourkia

80-87
- Full-text PDF
- Persian Abstract
DOI: https://doi.org/10.61882/jcbior.6.3.314

Letter

From empirical to precision therapy in ICUs: Rethinking antibiotic use after COVID-19

Hossein Azarmina, Niloofar Keikhaei, Kamyar Kharazmi

88-89
- Full-text PDF
DOI: https://doi.org/10.61882/jcbior.6.3.331